Table 1.
Receptor | Cell line | Radioligand or readout | Reference ligand (Ki, nM) | ADN-1184 Ki ± SEM (nM) |
---|---|---|---|---|
h 5-HT6 | CHO cells | [3H]LSD | 5-HT (33) | 16 ± 13 |
h 5-HT7 | CHO cells | [3H]LSD | 5-HT (0.8) | 0.50 ± 0.27 |
h 5-HT2A | HEK-293 cells | [3H]ketanserin | Ketanserin (0.3) | 2.0 ± 1.0 |
h 5-HT1A | HEK-293 cells | [3H]8-OH-DPAT | 8-OH-DPAT (0.4) | 173 ± 85 |
h 5-HT2C | HEK-293 cells | [3H]mesulergine | RS102221 (0.6) | 630 ± 370 |
h D2S | HEK-293 cells | [3H]methyl-spiperone | (+)butaclamol (0.04) | 18 ± 6 |
h D3 | CHO cells | [3H]methyl-spiperone | (+)butaclamol (0.04) | 20 ± 11 |
h D4 | CHO cells | [3H]methyl-spiperone | Clozapine (17) | 17 ± 7 |
h D1 | CHO cells | [3H]SCH23390 | SCH23390 (0.1) | 30 ± 13 |
h α1A | CHO cells | [3H]prazosin | Prazosin (0.04) | 0.84 ± 0.58 |
h α2C | CHO cells | [3H]RX 821002 | Yohimbine (0.5) | 8.5 ± 5.7 |
h H1 | HEK-293 cells | [3H]pyrilamine | Pyrilamine (1.7) | 116 ± 60 |
h M1 | CHO cells | [3H]pirenzepine | Pirenzepine (16) | >1000a |
h M2 | CHO cells | [3H]AF-DX 384 | Methoctramine (27) | >1000a |
h M3 | CHO cells | [3H]4-DAMP | 4-DAMP (0.44) | >1000a |
h M4 | CHO cells | [3H]4-DAMP | 4-DAMP (0.88) | >1000a |
h M5 | CHO cells | [3H]4-DAMP | 4-DAMP (0.48) | >1000a |
hERG | CHO cells | Inhibition of K + current | – | 2080 ± 550b |
Unless indicated, all experiments were carried out by Cerep.
Less than 10% inhibition of binding observed at a concentration of 1 μM (n = 2).
IC50 value. hERG channel current experiments were carried out by ChanTest.
h, human recombinant.